Background & Aims: Spontaneous resolution of hepatitis C virus (HCV) infections depends upon a
Introduction
Chronic hepatitis C virus (HCV) infection is a major public health concern worldwide. It is the leading cause of liver failure and reason for liver transplant in the US. Irrespective of clinical outcome, acute HCV infections are characterized by broad HCV-specific T cell responses that correlate with spontaneous viral clearance in a minority of individuals [1] . In most patients, however, this initial response fails to contain the virus and chronic disease results. Increased numbers of CD4 + regulatory T (reg) cells circulating in the bloodstream and accumulating in the liver have been implicated in the pathogenesis of chronic hepatitis C [2, 3] .
T reg cells constitute one of the major mechanisms underlying immunological homeostasis and self-tolerance [4] . In addition, T reg cells play a key role in moderating the immune response to infectious diseases, suppressing host tissue and organ damage that would occur in the absence of regulation [5] . Although key to maintaining immune homeostasis, a growing body of evidence suggests that T reg cells also contribute to the establishment and persistence of chronic infections, e.g., HCV [6, 7] . While no single marker exists, human T reg cells are classically identified by expression of the transcription factor, forkhead box P3 (FoxP3), and the cell surface expression of the interleukin (IL)-2 receptor α chain (CD25).
Two distinct T reg cell subsets are described in the literature: natural (n)T reg cells specific for self epitopes and generated by high-avidity selection in the thymus, and inducible (i)T reg cells that derive from conventional (CD4 + CD25 -FoxP3 -) T cells following stimulation in the periphery [8] . nT reg cells can induce the conversion of conventional T cells to iT reg cells via cytokine-dependent and -independent mechanisms, a process called infectious tolerance [9, 10] . Notably, the factors that affect expansion of the T reg cell population in cases of chronic hepatitis C remain to be fully delineated. Nonetheless, the consensus supports the heterogeneous nature of the expanded T reg cell population composed of both nT reg and iT reg cell subsets [11] .
promotes a T reg cell response among PBMCs derived from patients with persistent HCV infection.
This peptide exhibited human homology when evaluated using GenBank Basic Local Alignment Search Tool (BLAST) [12] . Further analysis using a new bioinformatics tool, JanusMatrix [13, 14] , demonstrated that this HCV peptide cross-reacts with HLA matched peptide sequences located within hundreds of human proteins. Our data suggest that HCV_G1_p7_794 engages preexisting nT reg cells as a consequence of this homology, induces infectious tolerance and the expansion of an iT reg cell population, which contributes to suppression of effector T (eff) cell activity in cases of chronic HCV infection. Table 1 .
JanusMatrix analysis
Crystal structure analyses of ternary, MHC:epitope:T cell receptor (TcR) complexes indicate that certain amino acid residues of a T cell epitope contact the MHC molecule while other residues contact the TcR [16] . JanusMatrix, a new bioinformatics tool, interrogates a potential T cell epitope from both its HLA-binding and TcR-facing aspects, and assesses TcR cross-reactivity with T cell epitopes encoded by other genomes [13, 14] . Those epitopes from two different genomic sources, e.g., HCV and human, that bind the same HLA molecules and present identical amino acids to the TcR are designated potentially cross-reactive, capable of stimulating the same TcR and triggering the same T cells to respond. In the analysis undertaken here, JanusMatrix divided the HCV HLA-DRB1-restricted epitopes (comprising the ICS described above) into TcR-facing and MHC-binding amino acid residues. The human protein database (UniProtKB) was then searched for TcR-facing epitopes that cross-react with the HCV epitopes. Figure 3B ). Importantly, the addition of HCV_G1_p7_794 alone (in the absence of anti-CD3 or IL-2) had no effect on the proliferation of CD3 Figure 1) .
JanusMatrix confirms T reg cell epitopes shared by HCV_G1_p7_974 and the human proteome
By comparing HCV G1_p7_794 with peptide sequences found in the human proteome, JanusMatrix analysis provided further insight into the capacity of HCV_G1_p7_794 to induce a T reg cell response by PBMCs derived from HCV-infected patients. As illustrated in Table 2 , HCV_G1_p7_794 contains five T cell epitopes, which cross-react with 152 putative human T cell epitopes contained in 264 different human proteins. Similarly, the human analog, p7_794, cross-reacts with putative T cell epitopes located within several hundred human proteins. In contrast, neither HCV_G1_NS4b_1941
(control ICS often used in the ex vivo experiments described above) nor any of the 18 other putative ICS, validated by their ability to elicit immune recognition and IFN-γ production by naïve human T cells ex vivo [17] , exhibited significant cross-reactivity with the human proteome. Moreover, HCV_G1_p7_794 induced substantially fewer naïve T cells to produce IFN-γ assessed by ELISpot assay, i.e., 64 + 75 versus 655 + 591 (mean ± SD number of spots/10 6 T cells, n=8) for HCV_G1_p7_794 and HCV_G1_NS4b, respectively; values are significantly different (p=0.021;
Mann-Whitney rank sum test). The relative inability to induce IFN-γ production supports our speculation that, rather than activate T eff cells, HCV_G1_p7_794 activates a cross-reactive nT reg cell population that normally functions to suppress autoimmune responses to a large number of human proteins, which contain a common peptide sequence (epitope).
Resolution of primary HCV infections is dependent upon the vigorous response of CD4 + and CD8 + T cells to multiple viral epitopes [23] . HCV persists in the majority of infected patients, however, by modifying and/or evading the host immune response. Purportedly, a variety of factors contribute to the diminished T cell responses observed in chronically infected patients including: viral mutation and escape linked to both CD4 and CD8 T cell failure, CD4 T cell anergy, CD8 T cell exhaustion, impaired dendritic cell function, and T reg cell-mediated suppression [2, 3, 6, 7, 24, 25] . The increased frequency of T reg cells found in the liver and circulating in the peripheral blood of chronically-infected patients, confirmed in the current study (Figure 2 ), provided an initial indication of the role of T reg cells in the pathogenesis of chronic hepatitis C [2, 3, 5, 11] . It remained unclear until recently, however, whether this increase represented the HCV epitope-specific response of T reg cells or the nonspecific consequence of chronic inflammation and liver disease [7] .
The ability of HCV-derived epitopes to stimulate T reg cell responses is well documented; epitopes associated with both structural and non-structural HCV proteins have been reported [20, 26] .
Using HLA class II-peptide tetramer complexes, other investigators quantified and characterized the response of T reg cell specific for single HCV epitopes [20, 26] . The study described herein is the first, however, to identify a promiscuous HCV peptide sequence (HCV_G1_p7_794) that exhibits extensive human homology and the ability to elicit a T reg cell response in a wide, HLA-diverse human population, such as the infected patient population shown in Table I . Unlike the T reg cell epitopes described previously, HCV_G1_p7_794 is an ICS composed of multiple HLA binding motifs able to bind a number of DRB1 alleles. Unfortunately, this precludes construction of an HLA-peptide tetramer complex and quantitation of the HCV_G1_p7_794-responsive cells. In accord with the literature, HCV_G1_p7_794 added to PBMCs cultures derived from HCV-infected patients, but not non-infected individuals or patients who cleared infection, induced a marked increase in CD3 + CD4 + FoxP3 + cells [20, 26] . In addition to expressing CD25, characteristic of T reg cells, the vast majority of these cells expressed CD39, a marker that distinguishes FoxP3 + T reg cells from activated T eff cells that transiently express FoxP3 [6, 19] .
In contrast to HCV_G1_p7_794, the human peptide analog (p7_794) elicited a significant increase in CD3 + CD4 + FoxP3 + cells in PBMC cultures derived from non-infected individuals with no evidence of prior HCV exposure, as well as HCV-infected patients. This finding is congruent with the suggestion that viral epitopes with human homology influence the pathogenesis of chronic HCV by activating preexisting, cross-reactive nT reg cells [11] . Indeed, extensive homology between the HCV polyprotein and proteins that comprise human proteome is well documented [27, 28] . JanusMatrix, a bioinformatics algorithm that interrogates potential T cell epitopes from both their HLA-binding and 
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HLA-DRB1-restricted epitope selection
HCV sequences were acquired from the Los Alamos database [1, 2] . Nine-mer amino acid sequences, capable of fitting the binding groove of HLA class II molecules and highly conserved across HCV genotype 1a and 1b isolates, were identified and scored for potential to bind eight common HLA class II (DRB1) alleles using bioinformatics tools [3] [4] [5] . HLA class II immunogenic consensus sequences (ICS) were identified and constructed by assembling potentially immunogenic 9-mers into 18-25 amino acid sequence [3] . ICS construction improves the probability that an epitope will be presented in the context of more than one HLA allele, thus broadening the response of an HLA-diverse human population. Twenty ICS derived from HCV genotypes 1a and 1b were synthesized as peptides using 9-fluoronylmethoxycarbonyl chemistry and purified >85% by 21st
Century Biochemicals (Marlboro, MA). Each of these "promiscuous" ICS contained between 5 and 28 predicted HLA binding motifs, and were bound by multiple HLA-DRB1 alleles in competitive binding assays as described previously [6, 7] . Each ICS was also evaluated for human homology (>7 shared identities per 9-mer frame) using GenBank BLAST [8] .
Peripheral blood mononuclear cell (PBMC) cultures
Cryopreserved PBMCs from participating subjects were thawed; suspended in HEPES-buffered RPMI1640 medium supplemented with 10% HuAB serum (Valley Biomedical, Winchester, VA), glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin; and rested overnight at 37 o C in a humidified, CO 2 incubator. On the following day, the PBMCs were centrifuged and resuspended in fresh medium containing 5% HuAB serum; 1 x 10 6 cells/ml were transferred to deep, flat-bottom, non- 
Flow cytometry
Stimulated PBMC were quantified and characterized in accordance with methods we described previously [9] . The following dye-conjugated mouse monoclonal antibodies were purchased from BioLegend (San Diego, CA) and used: CD3, CD4 (clone OKT4), CD8a (clone HIT8a); CD39 (clone A1), and CD304 (clone 14H4); anti-human CD25 (clone M-A251) and anti-human FoxP3 (clone 236a)
were purchased from BD Biosciences (San Jose, CA). Data were collected on a BD LSRII Flow Cytometer (BD Biosciences, San Jose, California) and analyzed using FlowJo software (Tree Star, Inc., Ashland, OR). All analyses were conducted using the appropriate isotype controls to correct for non-specific staining.
Statistical Analysis
The results were analyzed using the SigmaStat statistics program (Aspire Software International).
Means were compared using a non-paired Student's t test or a Mann-Whitney Rank Sum test.
Aggregate data were compared by one-way analysis of variance; the Dunnett's test determined which groups differed significantly. 
